medium
80%+ — of routine refills auto-approved
Target rate based on the 20-point clinical protocol gating refill auto-approval. Measured on protocol-eligible scripts, not all incoming refills.
ref: auto-approval-target
IgniteHealth · Methodology
Every number on this site has a footnote. This is where they resolve.
We label every claim with a confidence — high when the source is direct and sourceable, medium when the figure is directional, projection when the figure is modelled. We never publish a number without telling you which it is.
projection
+5–13 pp — PDC lift across MAC, MAD, MAH
Range of plausible PDC lift across the three Part D triple-weighted measures, derived from outreach-volume modelling. Actual lift varies by baseline adherence and member mix.
ref: pdc-lift-methodology
projection
$5–7.5M — in QBP bonus per 100K Medicare lives
Quality Bonus Payment range based on a 0.5-Star uplift at typical 2026 benchmark and rebate share assumptions ($1,150 PMPM benchmark, 65% rebate share). Plan-specific results depend on bid, region, and CMS rate announcement.
ref: qbp-bonus-math
medium
3–5 min — saved per routine refill review
Time-motion baseline for human refill review (3–5 min routine, 10–15 min complex). PrefillX automates the routine path, leaving exceptions to human review.
ref: review-time-baseline
projection
11 weeks — projected payback
Projected breakeven on PrefillX deployment for a 100K-life MA plan, assuming target auto-approval and outreach rates. Modelled, not observed.
ref: payback-modelling
projection
4.2 → 4.7 — projected Star Rating uplift
Illustrative half-star movement scenario for a plan moving from 4.2 to 4.7 Stars on Part D adherence measures, post-Tukey-outlier-deletion 2027 cut points.
ref: stars-uplift-illustration
medium
15K+ — members reached in pilot outreach
Cumulative count from pilot outreach campaigns. Specific to pilot deployment; not yet generalised.
ref: pilot-outreach-volume
high
0 — PHI incidents to date
Confirmed PHI breaches reported under HIPAA Breach Notification Rule. Independent of HIPAA compliance posture, which is also documented.
ref: phi-incidents-log
high
99.97% — reasoning-trace audit completeness
Share of decisions with a complete reasoning trace captured to the audit log, sampled across the production batch. Remainder are flagged for trace-completion before being released.
ref: audit-completeness-sampling
FDA Clinical Decision Support. PrefillX operates under FDA enforcement discretion (21st Century Cures Act §3060). It is not a 510(k) device. The pharmacist remains the decision-maker of record on every script.